FindTrial
Sign In

liposomal daunorubicin citrate

DRUG4 trials

Sponsors

University of Leicester, National Cancer Institute (NCI), Eastern Cooperative Oncology Group, AIDS Malignancy Consortium

Conditions

Breast CancerChronic Myelomonocytic LeukemiaLeukemiaPreviously Treated Myelodysplastic SyndromesRecurrent Adult Acute Myeloid LeukemiaRefractory Anemia With Excess BlastsRefractory Anemia With Excess Blasts in TransformationSarcoma

Phase 1

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
CompletedNCT00005942
National Cancer Institute (NCI)Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia +2
Start: 2000-03-31Updated: 2013-01-23
Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
NCT00004207
University of LeicesterBreast Cancer
Start: 1997-12-31Updated: 2014-06-24
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
TerminatedNCT00427414
AIDS Malignancy ConsortiumSarcoma
Start: 2008-09-30End: 2011-11-30Updated: 2015-04-29

Phase 2

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
CompletedNCT00005962
Eastern Cooperative Oncology GroupLeukemia
Start: 2000-10-04End: 2007-06-30Updated: 2023-06-22

Related Papers

Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group.
2009-10-0546 citations